Tri (hydroxymethyl) methylamine salt or an ethanol amine salt of (2S) - 2-ethoxy-3- (4-{2- [hexyl (2phenylethyl) amino] - 2 -oxoethoxy} phenyl) propanoic acid

Details for Australian Patent Application No. 2005317285 (hide)

Owner AstraZeneca AB

Inventors Booth, Rebecca J.; Dahlstrom, Mikael

Agent Davies Collison Cave

Pub. Number AU-A-2005317285

PCT Pub. Number WO2006/065214

Priority 0403072-2 16.12.04 SE

Filing date 14 December 2005

Wipo publication date 22 June 2006

International Classifications

C07C 235/20 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/195 (2006.01)

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/065214 Priority application(s): WO2006/065214

8 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005317286-Novel hydantoin derivatives as metalloproteinase inhibitors

2005317280-Nicotinic acetylcholine receptor ligands